Allergy Therapeutics plc

AIM:AGY Stok Raporu

Piyasa değeri: UK£219.3m

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Allergy Therapeutics Yönetim

Yönetim kriter kontrolleri 3/4

Allergy Therapeutics' CEO is Manuel Llobet, appointed in Jul 2009, has a tenure of 15.25 years. total yearly compensation is £411.98K, comprised of 83% salary and 17% bonuses, including company stock and options. directly owns 0.1% of the company’s shares, worth £230.07K. The average tenure of the management team and the board of directors is 8.8 years and 2.4 years respectively.

Anahtar bilgiler

Manuel Llobet

İcra Kurulu Başkanı

UK£412.0k

Toplam tazminat

CEO maaş yüzdesi83.0%
CEO görev süresi15.3yrs
CEO sahipliği0.1%
Yönetim ortalama görev süresi8.8yrs
Yönetim Kurulu ortalama görev süresi2.4yrs

Son yönetim güncellemeleri

Recent updates

Not Many Are Piling Into Allergy Therapeutics plc (LON:AGY) Just Yet

Sep 12
Not Many Are Piling Into Allergy Therapeutics plc (LON:AGY) Just Yet

Allergy Therapeutics plc's (LON:AGY) 28% Share Price Surge Not Quite Adding Up

May 21
Allergy Therapeutics plc's (LON:AGY) 28% Share Price Surge Not Quite Adding Up

Allergy Therapeutics plc (LON:AGY) Surges 28% Yet Its Low P/S Is No Reason For Excitement

Dec 18
Allergy Therapeutics plc (LON:AGY) Surges 28% Yet Its Low P/S Is No Reason For Excitement

CEO Tazminat Analizi

Manuel Llobet'un ücretlendirmesi Allergy Therapeutics'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Dec 31 2023n/an/a

-UK£50m

Sep 30 2023n/an/a

-UK£47m

Jun 30 2023UK£412kUK£342k

-UK£43m

Mar 31 2023n/an/a

-UK£36m

Dec 31 2022n/an/a

-UK£29m

Sep 30 2022n/an/a

-UK£21m

Jun 30 2022UK£665kUK£332k

-UK£14m

Mar 31 2022n/an/a

-UK£10m

Dec 31 2021n/an/a

-UK£5m

Sep 30 2021n/an/a

-UK£1m

Jun 30 2021UK£662kUK£324k

UK£3m

Mar 31 2021n/an/a

UK£5m

Dec 31 2020n/an/a

UK£7m

Sep 30 2020n/an/a

UK£7m

Jun 30 2020UK£614kUK£303k

UK£7m

Mar 31 2020n/an/a

UK£8m

Dec 31 2019n/an/a

UK£8m

Sep 30 2019n/an/a

UK£6m

Jun 30 2019UK£557kUK£295k

UK£3m

Mar 31 2019n/an/a

UK£117k

Dec 31 2018n/an/a

-UK£3m

Sep 30 2018n/an/a

-UK£5m

Jun 30 2018UK£556kUK£286k

-UK£8m

Tazminat ve Piyasa: Manuel 'ın toplam tazminatı ($USD 550.81K ) UK pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 771.02K ).

Tazminat ve Kazançlar: Manuel's compensation has been consistent with company performance over the past year.


CEO

Manuel Llobet (59 yo)

15.3yrs

Görev süresi

UK£411,982

Tazminat

Mr. Manuel Llobet has been the Chief Executive Officer of Allergy Therapeutics plc since July 2009. Mr. Llobet joined Allergy in September 2009 following the successful refinancing by Azure Ventures Limite...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Manuel Llobet
CEO & Executive Director15.3yrsUK£411.98k0.10%
£ 230.1k
Shaun Furlong
CFO & Executive Director1.2yrsVeri yok0.000030%
£ 65.8
Beverly Lees
Group Operations Director8.8yrsVeri yokVeri yok
Murray Skinner
Chief Scientific Officer8.8yrsVeri yokVeri yok
Santiago Puig
Business Development Director15yrsVeri yokVeri yok
Sue Baker
Head of Human Resourcesno dataVeri yokVeri yok
Simon Piggott
Head of Clinical Science7.1yrsVeri yokVeri yok
Alan Bullimore
Head of Communication & Market Developmentno dataVeri yokVeri yok
Russell Picket
Group Financial Controllerno dataVeri yokVeri yok
Karley Charlotte Cheesman
Company Secretary1.7yrsVeri yokVeri yok
Matthew Heath
Principal Scientistno dataVeri yokVeri yok

8.8yrs

Ortalama Görev Süresi

Deneyimli Yönetim: AGY's management team is seasoned and experienced (8.8 years average tenure).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Manuel Llobet
CEO & Executive Director15.3yrsUK£411.98k0.10%
£ 230.1k
Shaun Furlong
CFO & Executive Directorless than a yearVeri yok0.000030%
£ 65.8
Babatunde Otulana
Senior Independent Director7.3yrsUK£44.50k0.0010%
£ 2.3k
Peter Jensen
Independent Chairman14yrsUK£94.00k0.044%
£ 96.6k
Johannes Ring
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Hendrik Kees Nolte
Chairman of Scientific Advisory Boardno dataVeri yokVeri yok
Anthony Frew
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Lawrence Du Buske
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Anthony Parker
Non-Executive Director1.8yrsVeri yok0.040%
£ 88.6k
Cheryl Macdiarmid
Independent Non-Executive Director3yrsUK£40.00kVeri yok
Zheqing Shen
Non-Executive Director1.8yrsVeri yok0.0019%
£ 4.1k
David William Ball
Independent Non-Executive Directorless than a yearVeri yokVeri yok

2.4yrs

Ortalama Görev Süresi

57.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: AGY's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.